Matches in Nanopublications for { ?s ?p "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184565.RAbqs3G6lHVQPxzjOxa4dZbEQnfMEfFek6CrtDaC1Eg-M130_provenance.
- NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_provenance.
- assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP524471.RAnpT0Mvm9AYiu11_SjzjGqihaAdIRWkd4pPg3uELcwys130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524471.RAnpT0Mvm9AYiu11_SjzjGqihaAdIRWkd4pPg3uELcwys130_provenance.
- NP917344.RAW_IinEz2_u7Z_Yra7jaMmRMT46JCkUvhDa-jJHYD4zY130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917344.RAW_IinEz2_u7Z_Yra7jaMmRMT46JCkUvhDa-jJHYD4zY130_provenance.
- NP747435.RALaKY9-Yud8bFK9qDdxwsUCdXVaO8zNNQr-CiLz--Kdk130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747435.RALaKY9-Yud8bFK9qDdxwsUCdXVaO8zNNQr-CiLz--Kdk130_provenance.
- NP917343.RAtfBniGHA3ozrszun3DyHEEdB-N50w8uzNP6MjGrDx_g130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917343.RAtfBniGHA3ozrszun3DyHEEdB-N50w8uzNP6MjGrDx_g130_provenance.
- NP524548.RA3vs-Z8Q3TP5qJRpTcMphgAN48JVStzs3BtbDiyJxMYw130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524548.RA3vs-Z8Q3TP5qJRpTcMphgAN48JVStzs3BtbDiyJxMYw130_provenance.
- NP929428.RALAg1UTE0NAxQIfHRx4clmaPzb9Ux2z2BvYAxCaCUSFM130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929428.RALAg1UTE0NAxQIfHRx4clmaPzb9Ux2z2BvYAxCaCUSFM130_provenance.
- NP917345.RALH2NifIdn6K6qI1IDfRj5KkbevX-YPAm_s2f0jr7XXI130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917345.RALH2NifIdn6K6qI1IDfRj5KkbevX-YPAm_s2f0jr7XXI130_provenance.